Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 826.75
-9.45 (-1.13%)
Aug 7, 2025, 11:30 AM IST
Laurus Labs Employees
Laurus Labs had 6,167 employees as of March 31, 2025. The number of employees increased by 160 or 2.66% compared to the previous year.
Employees
6,167
Change (1Y)
160
Growth (1Y)
2.66%
Revenue / Employee
9.61M INR
Profits / Employee
825.09K INR
Market Cap
451.40B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6,167 | 160 | 2.66% |
| Mar 31, 2024 | 6,007 | 254 | 4.42% |
| Mar 31, 2023 | 5,753 | 449 | 8.47% |
| Mar 31, 2022 | 5,304 | 496 | 10.32% |
| Mar 31, 2021 | 4,808 | 936 | 24.17% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Mankind Pharma | 26,978 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
Laurus Labs News
- 10 days ago - Why are Laurus Labs shares up over 2% today? Explained - Business Upturn
- 10 days ago - Stocks to watch on brokerages, July 28: Mphasis, Cipla, Kotak Bank, Laurus Labs, IDFC First Bank, Bank of Baorda, SBI Cards, and more in focus - Business Upturn
- 10 days ago - Antique maintains hold on Laurus Labs, raises target to Rs 700 as CDMO momentum persists but visibility stays limited - Business Upturn
- 10 days ago - Motilal Oswal maintains buy on Laurus Labs, raises target to Rs 970 on strong CDMO-led earnings momentum - Business Upturn
- 10 days ago - Kotak Institutional Equities maintains sell on Laurus Labs, raises target to Rs 555 as earnings recovery seen priced in - Business Upturn
- 10 days ago - Jefferies maintains underperform on Laurus Labs, raises target to Rs 590 as margin concerns persist despite Q1 beat - Business Upturn
- 10 days ago - Goldman Sachs maintains sell on Laurus Labs, raises target to Rs 675 citing limited visibility despite margin optimism - Business Upturn
- 12 days ago - Laurus Labs posts sharp rise in net profit for Q1FY26 - The Times of India